BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Overview Fund Activity
Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

328 hedge funds and large institutions have $8.76B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2022 Q2 according to their latest regulatory filings, with 109 funds opening new positions, 98 increasing their positions, 98 reducing their positions, and 80 closing their positions.

Holders
328
Holders Change
+23
Holders Change %
+7.54%
% of All Funds
5.55%
Holding in Top 10
30
Holding in Top 10 Change
+20
Holding in Top 10 Change %
+200%
% of All Funds
0.51%
New
109
Increased
98
Reduced
98
Closed
80
Calls
$86.5M
Puts
$47.5M
Net Calls
+$39M
Net Calls Change
+$17.6M

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$443M
2
FCM
2
Farallon Capital Management
California
$284M
3
UOC
3
UBS O'Connor
Illinois
$283M
4
PCM
4
Pentwater Capital Management
Florida
$208M
5
SFM
5
Soros Fund Management
New York
$183M

Top Sellers

1
Capital World Investors
1
Capital World Investors
California
$385M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$157M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$17.1M
4
Allspring Global Investments
4
Allspring Global Investments
North Carolina
$133M
5
Capital International Investors
5
Capital International Investors
California
$222M
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
$105M +$50.4M +345,694 +93%
VI
27
Versor Investments
New York
$102M +$102M +698,793 New
Millennium Management
28
Millennium Management
New York
$101M +$99.1M +680,426 +5,929%
EP
29
Eversept Partners
New York
$92.2M -$1.73M -11,872 -2%
Charles Schwab
30
Charles Schwab
California
$91.4M +$3.38M +23,228 +4%
Norges Bank
31
Norges Bank
Norway
$88M +$17.8M +121,864 +25%
Northern Trust
32
Northern Trust
Illinois
$83.7M +$7.03M +48,218 +9%
AAM
33
Alpine Associates Management
Florida
$77.8M +$77.8M +533,800 New
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
$76M +$846K +5,809 +1%
CC
35
Carlson Capital
Texas
$74.3M +$74.3M +510,000 New
Man Group
36
Man Group
United Kingdom
$63.5M – – –
AllianceBernstein
37
AllianceBernstein
Tennessee
$51.3M -$42.5M -291,459 -45%
UBS AM
38
UBS AM
Illinois
$49.4M +$40.5M +278,098 +459%
Balyasny Asset Management
39
Balyasny Asset Management
Illinois
$48.6M +$48.6M +333,839 New
Tudor Investment Corp
40
Tudor Investment Corp
Connecticut
$47.8M +$47.8M +327,735 New
Lord, Abbett & Co
41
Lord, Abbett & Co
New Jersey
$46.3M -$19.8M -135,673 -30%
TCM
42
Tang Capital Management
California
$40.8M +$40.8M +280,000 New
UBS Group
43
UBS Group
Switzerland
$39.9M +$34.4M +236,397 +628%
FFM
44
Fairmount Funds Management
Pennsylvania
$38.5M +$3.63M +24,892 +10%
RHJA
45
Rice Hall James & Associates
California
$38.3M -$2.04M -13,976 -5%
WCMNY
46
Westchester Capital Management (New York)
New York
$35.4M +$35.4M +242,790 New
HRCM
47
Hood River Capital Management
Florida
$34.8M +$1.04M +7,133 +3%
Citadel Advisors
48
Citadel Advisors
Florida
$34.5M +$13.2M +90,863 +62%
Allianz Asset Management
49
Allianz Asset Management
Germany
$34.3M +$23.7M +162,825 +225%
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$33.3M +$32.2M +221,116 +2,898%
1
2
3 4 5